Taro Pharmaceutical Industries Ltd (NYSE:TARO)

75.85
Delayed Data
As of Oct 21
 +0.14 / +0.18%
Today’s Change
72.97
Today|||52-Week Range
109.42
-10.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues154.6M159.0M176.4M179.9M
 
 
 
 
 
Cost of Goods Sold50.2M45.9M53.9M55.5M
 
 
 
 
 
Depreciation And Amortization4.3M4.5M4.9M4.9M
 
 
 
 
 
 
Operating ExpensesGross Income100.1M108.6M117.5M119.5M
 
 
 
 
 
General Expenses36.9M33.8M38.6M43.8M
 
 
 
 
 
Research And Development13.3M14.7M14.7M20.5M
 
 
 
 
 
Total Operating Expenses91.5M84.3M97.4M104.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income63.2M74.7M78.9M75.7M
 
 
 
 
 
Extraordinary Credit0.004.0M0.00--
 
 
Extraordinary Charge0.000.000.00-322.0K
 
 
Other Expenses10.6M-6.0M32.1M-9.8M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income81.5M81.8M119.4M74.1M
 
 
 
 
 
Income Taxes-14.1M-19.2M-25.8M-15.6M
 
 
 
 
 
Minority Interest-151.0K-12.0K-164.0K-42.0K
 
 
 
 
 
Net Income67.3M62.6M93.5M58.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS39.4M39.4M38.9M38.5M
 
 
 
 
 
Shares To Calculate EPS Diluted39.4M39.4M38.9M38.5M
 
 
 
 
 
 
Earnings Per ShareEPS$1.71$1.59$2.40$1.52
 
 
 
 
 
EPS Diluted$1.71$1.59$2.40$1.52